Novel Compounds as PHD Inhibitors for Treating Heart, Lung, Liver, and Kidney Diseases
- ACS Med Chem Lett. 2021 Nov 4;12(12):1868-1869. doi: 10.1021/acsmedchemlett.1c00570.
Affiliations
- 1. Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID: 34917238
DOI: 10.1021/acsmedchemlett.1c00570
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: HIF/HIF Prolyl-HydroxylaseResearch Areas: Cardiovascular Disease